PIMECROLIMUS

PIMECROLIMUS was reported 1797 times

PIMECROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ERYTHROPLASIA OF PENIS 1 0.5000
1 IRIDOSCHISIS 3 0.4286
2 LICHEN NITIDUS 5 0.1429
3 LUPUS MILIARIS DISSEMINATUS FACIEI 1 0.1429
4 FOLLICULAR ECZEMA 1 0.1111
5 CUTANEOUS T-CELL LYMPHOMA STAGE III 2 0.0870
6 CONFLUENT AND RETICULATE PAPILLOMATOSIS 1 0.0833
7 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV 1 0.0833
8 EXCESSIVE DYNAMIC AIRWAY COLLAPSE 2 0.0769
9 FUNGAL BALANITIS 1 0.0556
10 NOTALGIA PARAESTHETICA 1 0.0476
11 GRANULOMATOUS ROSACEA 2 0.0408
12 CARDIAC PACEMAKER ADJUSTMENT 1 0.0370
13 DEMODICIDOSIS 3 0.0326
14 LIMBIC ENCEPHALITIS 9 0.0326
15 FOLLICULAR LYMPHOMA STAGE IV 1 0.0244
16 KAPOSI'S VARICELLIFORM ERUPTION 1 0.0227
17 FASCIAL INFECTION 1 0.0222
18 AUTOIMMUNE BLISTERING DISEASE 1 0.0217
19 TINEA VERSICOLOUR 7 0.0194
20 INFUSION SITE DRYNESS 1 0.0185
21 IMMINENT ABORTION 1 0.0182
22 ANDROGENETIC ALOPECIA 5 0.0176
23 HERPES PHARYNGITIS 1 0.0175
24 TRANSIENT ACANTHOLYTIC DERMATOSIS 5 0.0170
25 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 5 0.0165
26 ACTIVATED PARTIAL THROMBOPLASTIN TIME 1 0.0164
27 NECROBIOSIS LIPOIDICA DIABETICORUM 1 0.0159
28 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0134
29 HAMARTOMA 1 0.0132
30 ACTINIC ELASTOSIS 1 0.0132
31 KERATOSIS FOLLICULAR 1 0.0128
32 STEROID WITHDRAWAL SYNDROME 13 0.0127
33 EAR, NOSE AND THROAT INFECTION 1 0.0122
34 CUTANEOUS AMYLOIDOSIS 1 0.0119
35 APPLICATION SITE ECZEMA 1 0.0115
36 NON-HODGKIN'S LYMPHOMA RECURRENT 1 0.0109
37 ANAL RASH 1 0.0104
38 MULTIPLE DRUG HYPERSENSITIVITY 1 0.0104
39 BENIGN LYMPH NODE NEOPLASM 1 0.0102
40 ERYTHEMA MIGRANS 1 0.0100
41 INTERTRIGO 5 0.0092
42 MUSCLE CONTUSION 1 0.0091
43 ADENOIDITIS 1 0.0079
44 BED BUG INFESTATION 1 0.0079
45 CHRONIC SPONTANEOUS URTICARIA 9 0.0078
46 TOPICAL STEROID WITHDRAWAL REACTION 3 0.0077
47 ADRENAL SUPPRESSION 6 0.0071
48 CIRCUMCISION 1 0.0071
49 RETINAL TOXICITY 7 0.0068
50 EMBOLIA CUTIS MEDICAMENTOSA 5 0.0063
51 INTESTINAL STRANGULATION 1 0.0062
52 APPLICATION SITE WOUND 1 0.0061
53 EPIDERMODYSPLASIA VERRUCIFORMIS 1 0.0060
54 LYMPH NODE PALPABLE 1 0.0058
55 EYELID BLEEDING 1 0.0058
56 BILIARY CYST 1 0.0057
57 LICHENIFICATION 2 0.0049
58 SMOOTH MUSCLE CELL NEOPLASM 2 0.0048
59 DISSOCIATIVE IDENTITY DISORDER 1 0.0048
60 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 1 0.0046
61 VULVAL DISORDER 3 0.0045
62 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
63 ECZEMA HERPETICUM 2 0.0043
64 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 73 0.0043
65 BIOPSY SKIN ABNORMAL 1 0.0042
66 CANCER IN REMISSION 1 0.0041
67 GRANULOMATOUS DERMATITIS 1 0.0041
68 SKIN DISCOMFORT 11 0.0041
69 DERMATITIS ATOPIC 212 0.0040
70 KLEBSIELLA URINARY TRACT INFECTION 1 0.0038
71 APPLICATION SITE MASS 1 0.0036
72 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
73 HEPATIC CANCER RECURRENT 1 0.0035
74 SALPINGECTOMY 2 0.0035
75 PORPHYRIA ACUTE 5 0.0035
76 EAR INFLAMMATION 1 0.0035
77 NERVE BLOCK 2 0.0034
78 EOSINOPHILIC PNEUMONIA CHRONIC 1 0.0034
79 INSULIN RESISTANCE 7 0.0034
80 CANDIDA SEPSIS 3 0.0033
81 CHANGE IN SUSTAINED ATTENTION 1 0.0033
82 ROSACEA 15 0.0032
83 PERIORAL DERMATITIS 2 0.0031
84 EXPOSURE TO ALLERGEN 1 0.0031
85 ALLERGY TO ARTHROPOD BITE 1 0.0031
86 NASAL CRUSTING 2 0.0031
87 EYELID RASH 3 0.0031
88 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
89 LYMPHOCYTIC INFILTRATION 3 0.0030
90 BRAIN MASS 1 0.0030
91 MASS EXCISION 1 0.0029
92 CONJUNCTIVITIS BACTERIAL 1 0.0029
93 KYPHOSIS 5 0.0028
94 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
95 LIVIDITY 1 0.0027
96 BONE TUBERCULOSIS 1 0.0026
97 NAIL PITTING 1 0.0025
98 FACTOR V LEIDEN MUTATION 1 0.0025
99 LIP ERYTHEMA 2 0.0025
100 MYCOSIS FUNGOIDES 2 0.0024
101 CARDIAC VENTRICULAR DISORDER 1 0.0024
102 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
103 EXPOSURE VIA EYE CONTACT 1 0.0024
104 CARBON MONOXIDE POISONING 1 0.0023
105 CUTANEOUS SARCOIDOSIS 1 0.0023
106 LACK OF INJECTION SITE ROTATION 4 0.0023
107 GINGIVAL BLISTER 1 0.0023
108 EYELID INFECTION 1 0.0023
109 SKIN FISSURES 44 0.0022
110 ALLERGY TO ARTHROPOD STING 1 0.0022
111 MACULE 6 0.0022
112 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
113 SCROTAL SWELLING 2 0.0021
114 MECHANICAL URTICARIA 1 0.0021
115 HUMAN HERPESVIRUS 6 INFECTION 4 0.0021
116 PUSTULE 5 0.0021
117 KERATIC PRECIPITATES 1 0.0021
118 SKIN TEXTURE ABNORMAL 2 0.0021
119 BLOOD CREATINE ABNORMAL 1 0.0021
120 ECZEMA NUMMULAR 1 0.0020
121 EYELID IRRITATION 5 0.0020
122 CORNEAL SCAR 1 0.0020
123 ECZEMA 104 0.0020
124 EYELID PAIN 4 0.0020
125 PERIORBITAL SWELLING 11 0.0019
126 PHYSICAL DECONDITIONING 5 0.0019
127 HEPATIC ADENOMA 1 0.0019
128 EYELIDS PRURITUS 6 0.0019
129 NEURODERMATITIS 7 0.0019
130 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
131 SKIN SWELLING 16 0.0018
132 ACARODERMATITIS 2 0.0018
133 SEBORRHOEIC DERMATITIS 3 0.0018
134 BLOOD INSULIN INCREASED 1 0.0018
135 ECZEMA EYELIDS 1 0.0018
136 NAIL BED BLEEDING 1 0.0018
137 METAL POISONING 1 0.0017
138 GROWTH RETARDATION 5 0.0017
139 ADENOMYOSIS 1 0.0017
140 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
141 HELLP SYNDROME 1 0.0016
142 XEROSIS 2 0.0016
143 LUPUS NEPHRITIS 3 0.0016
144 DERMATOSIS 1 0.0016
145 IMPAIRED QUALITY OF LIFE 23 0.0016
146 NASAL PRURITUS 2 0.0016
147 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
148 ACTINIC KERATOSIS 4 0.0015
149 REBOUND ATOPIC DERMATITIS 3 0.0015
150 SKIN DEPIGMENTATION 2 0.0015
151 EPISCLERITIS 1 0.0014
152 ANGULAR CHEILITIS 1 0.0014
153 APPLICATION SITE INFLAMMATION 2 0.0014
154 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
155 SKIN PLAQUE 12 0.0014
156 PAPULE 10 0.0014
157 INFUSION SITE INFLAMMATION 1 0.0014
158 SKIN WEEPING 5 0.0014
159 CERVICAL RADICULOPATHY 1 0.0014
160 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
161 POST HERPETIC NEURALGIA 2 0.0014
162 NOROVIRUS INFECTION 2 0.0014
163 EYELID MARGIN CRUSTING 4 0.0014
164 GASTROINTESTINAL SCARRING 1 0.0014
165 DANDRUFF 3 0.0014
166 FIBROCYSTIC BREAST DISEASE 1 0.0014
167 LOCAL REACTION 1 0.0013
168 SKIN HAEMORRHAGE 20 0.0013
169 IMPETIGO 2 0.0013
170 ASTIGMATISM 2 0.0013
171 ARTERIAL RUPTURE 1 0.0013
172 ALLERGIC COUGH 1 0.0013
173 ERYTHEMA OF EYELID 7 0.0013
174 EYE ALLERGY 2 0.0013
175 BLOOD FIBRINOGEN INCREASED 1 0.0013
176 EYELID EXFOLIATION 1 0.0013
177 HERPES ZOSTER DISSEMINATED 1 0.0012
178 ACNE PUSTULAR 1 0.0012
179 ERYTHRODERMIC PSORIASIS 1 0.0012
180 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
181 ARTHROPOD STING 2 0.0012
182 DERMATITIS 25 0.0012
183 INFECTED BITE 1 0.0012
184 ROTATOR CUFF REPAIR 2 0.0011
185 DERMATITIS CONTACT 13 0.0011
186 PIGMENTATION DISORDER 7 0.0011
187 SKIN HYPOPIGMENTATION 2 0.0011
188 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0011
189 SKIN WRINKLING 3 0.0011
190 ENTEROCOLITIS INFECTIOUS 1 0.0011
191 HAEMOCHROMATOSIS 1 0.0011
192 SKIN INFECTION 12 0.0011
193 INTERVERTEBRAL DISCITIS 2 0.0011
194 HYPERMETROPIA 1 0.0011
195 LIPOATROPHY 1 0.0011
196 ADRENAL DISORDER 2 0.0010
197 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
198 BLOOD IRON ABNORMAL 1 0.0010
199 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
200 HYPOGONADISM 1 0.0010
201 AUTONOMIC NEUROPATHY 1 0.0010
202 REBOUND ECZEMA 2 0.0010
203 BREAST DISCOMFORT 1 0.0010
204 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
205 INFUSION SITE DISCOMFORT 1 0.0010
206 EYE PRURITUS 32 0.0010
207 CARPAL TUNNEL DECOMPRESSION 1 0.0009
208 SKIN EXFOLIATION 80 0.0009
209 SCRATCH 10 0.0009
210 EYE CONTUSION 2 0.0009
211 IDIOPATHIC URTICARIA 1 0.0009
212 BONE NEOPLASM 1 0.0009
213 CHAPPED LIPS 4 0.0009
214 CONJUNCTIVITIS 17 0.0009
215 ACINETOBACTER INFECTION 1 0.0009
216 NEPHROSCLEROSIS 1 0.0009
217 TEMPERATURE REGULATION DISORDER 2 0.0009
218 ESSENTIAL TREMOR 1 0.0009
219 ARTERIAL HAEMORRHAGE 1 0.0009
220 CORTISOL DECREASED 1 0.0009
221 ORAL HERPES 17 0.0009
222 DISCOMFORT 53 0.0009
223 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
224 THERAPEUTIC RESPONSE SHORTENED 28 0.0008
225 FULL BLOOD COUNT INCREASED 1 0.0008
226 EMBOLISM ARTERIAL 1 0.0008
227 DRY SKIN 111 0.0008
228 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
229 EYELID SKIN DRYNESS 1 0.0008
230 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
231 FEBRILE CONVULSION 1 0.0008
232 INFUSION SITE WARMTH 1 0.0008
233 SKIN HYPERPIGMENTATION 7 0.0008
234 DERMAL CYST 2 0.0008
235 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
236 LUPUS VULGARIS 1 0.0008
237 DERMATOMYOSITIS 2 0.0008
238 SCAB 9 0.0008
239 APPENDICITIS PERFORATED 2 0.0008
240 LIP HAEMORRHAGE 1 0.0008
241 APPLICATION SITE WARMTH 1 0.0008
242 DACRYOSTENOSIS ACQUIRED 1 0.0008
243 APPLICATION SITE PAIN 17 0.0008
244 NON-HODGKIN'S LYMPHOMA 1 0.0008
245 AZOTAEMIA 3 0.0008
246 BLEPHARITIS 3 0.0007
247 CYSTITIS NONINFECTIVE 1 0.0007
248 FUNGAL SKIN INFECTION 3 0.0007
249 BODY MASS INDEX INCREASED 1 0.0007
250 CHEILITIS 4 0.0007
251 SLEEP DISORDER 52 0.0007
252 HAEMATOTOXICITY 7 0.0007
253 CORNEAL OPACITY 1 0.0007
254 EYE IRRITATION 42 0.0007
255 BILIARY TRACT DISORDER 1 0.0007
256 DRY EYE 36 0.0007
257 HALLUCINATIONS, MIXED 3 0.0007
258 MAST CELL ACTIVATION SYNDROME 1 0.0007
259 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
260 RESPIRATORY SYMPTOM 2 0.0007
261 PURULENT DISCHARGE 3 0.0007
262 NAIL INFECTION 1 0.0007
263 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
264 FAT TISSUE INCREASED 1 0.0007
265 RASH MACULAR 24 0.0007
266 CONJUNCTIVITIS ALLERGIC 1 0.0007
267 MYASTHENIA GRAVIS CRISIS 1 0.0007
268 RHINITIS ALLERGIC 3 0.0007
269 ANGIOPLASTY 1 0.0007
270 HYPOSMIA 1 0.0007
271 SUSPECTED OFF LABEL USE 3 0.0007
272 EPICONDYLITIS 1 0.0007
273 LIP DRY 6 0.0007
274 ABDOMINAL HERNIA 3 0.0007
275 GENITAL HERPES 1 0.0007
276 PORTAL HYPERTENSION 2 0.0006
277 NEOPLASM SKIN 1 0.0006
278 ERYTHEMA MULTIFORME 6 0.0006
279 COITAL BLEEDING 1 0.0006
280 SWELLING OF EYELID 4 0.0006
281 OCULAR HYPERAEMIA 30 0.0006
282 LIMB DEFORMITY 1 0.0006
283 EYE INFLAMMATION 6 0.0006
284 EXPOSURE TO TOXIC AGENT 2 0.0006
285 RASH VESICULAR 3 0.0006
286 COSTOCHONDRITIS 1 0.0006
287 DIABETIC NEUROPATHY 3 0.0006
288 APPLICATION SITE SWELLING 3 0.0006
289 PRODUCT DOSE OMISSION IN ERROR 17 0.0006
290 SKIN MASS 4 0.0006
291 HEPATORENAL SYNDROME 1 0.0006
292 DEAFNESS BILATERAL 1 0.0006
293 HEPATOTOXICITY 13 0.0006
294 SKIN LESION 16 0.0006
295 MILIARIA 1 0.0006
296 EYE DISCHARGE 6 0.0006
297 INJECTION SITE DISCOMFORT 6 0.0006
298 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
299 GENERALISED OEDEMA 7 0.0006
300 DEVICE ALARM ISSUE 1 0.0006
301 PRODUCT PRESCRIBING ISSUE 12 0.0006
302 THERAPEUTIC RESPONSE DECREASED 33 0.0005
303 PRURITUS 209 0.0005
304 BODY TEMPERATURE ABNORMAL 1 0.0005
305 SENSITIVE SKIN 4 0.0005
306 LYMPH NODE PAIN 1 0.0005
307 PRODUCT USE IN UNAPPROVED INDICATION 131 0.0005
308 BONE MARROW TRANSPLANT 1 0.0005
309 MECHANICAL VENTILATION 1 0.0005
310 SKIN ATROPHY 3 0.0005
311 THYROID MASS 2 0.0005
312 GINGIVAL DISORDER 2 0.0005
313 FOOD ALLERGY 4 0.0005
314 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
315 ALCOHOL INTERACTION 1 0.0005
316 THERAPY PARTIAL RESPONDER 8 0.0005
317 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
318 BODY TEMPERATURE DECREASED 5 0.0005
319 HYPERAEMIA 1 0.0005
320 HYPERPHAGIA 2 0.0005
321 SKIN DISCOLOURATION 23 0.0005
322 EAR HAEMORRHAGE 1 0.0005
323 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
324 DERMATITIS ACNEIFORM 3 0.0005
325 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
326 SELF-MEDICATION 2 0.0005
327 TREATMENT FAILURE 40 0.0005
328 MICROCYTIC ANAEMIA 1 0.0005
329 BODY TEMPERATURE FLUCTUATION 1 0.0005
330 INFUSION SITE ERYTHEMA 4 0.0005
331 EAR SWELLING 1 0.0005
332 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
333 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
334 HORDEOLUM 2 0.0005
335 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
336 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
337 APPLICATION SITE URTICARIA 1 0.0004
338 OCULAR DISCOMFORT 5 0.0004
339 THERAPY NON-RESPONDER 20 0.0004
340 IRON DEFICIENCY 2 0.0004
341 RASH PRURITIC 24 0.0004
342 RASH 193 0.0004
343 BLOOD LOSS ANAEMIA 1 0.0004
344 BRAIN OPERATION 1 0.0004
345 LICHEN PLANUS 1 0.0004
346 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
347 EXPOSURE VIA SKIN CONTACT 11 0.0004
348 SEASONAL ALLERGY 6 0.0004
349 INGROWING NAIL 1 0.0004
350 SKIN ABRASION 2 0.0004
351 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
352 FEAR OF INJECTION 3 0.0004
353 LONG QT SYNDROME 1 0.0004
354 AUTOIMMUNE DISORDER 4 0.0004
355 CARTILAGE INJURY 1 0.0004
356 FOOT OPERATION 2 0.0004
357 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
358 DEVICE INFUSION ISSUE 1 0.0004
359 PEMPHIGOID 3 0.0004
360 ENDODONTIC PROCEDURE 1 0.0004
361 PSORIATIC ARTHROPATHY 16 0.0004
362 ABDOMINAL INFECTION 1 0.0004
363 LACTOSE INTOLERANCE 1 0.0004
364 INITIAL INSOMNIA 4 0.0004
365 MENOPAUSE 1 0.0004
366 INFUSION SITE PAIN 5 0.0004
367 BLOOD CHLORIDE DECREASED 1 0.0004
368 MULTIPLE ALLERGIES 3 0.0004
369 FOOD CRAVING 2 0.0004
370 EXFOLIATIVE RASH 1 0.0004
371 FURUNCLE 3 0.0004
372 RASH ERYTHEMATOUS 18 0.0004
373 ERYTHEMA 77 0.0004
374 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
375 GASTROINTESTINAL INJURY 1 0.0004
376 PAIN OF SKIN 10 0.0004
377 PHARYNGITIS STREPTOCOCCAL 4 0.0004
378 AUTISM SPECTRUM DISORDER 2 0.0004
379 HYPERKERATOSIS 2 0.0004
380 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
381 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
382 EOSINOPHILIC OESOPHAGITIS 1 0.0004
383 EOSINOPHIL COUNT INCREASED 3 0.0004
384 ACUTE PULMONARY OEDEMA 2 0.0004
385 APPLICATION SITE PRURITUS 8 0.0004
386 PSORIASIS 46 0.0004
387 INTENTIONAL DOSE OMISSION 10 0.0004
388 EYE SWELLING 13 0.0003
389 ADENOVIRUS INFECTION 1 0.0003
390 SKIN WARM 2 0.0003
391 FLUID OVERLOAD 5 0.0003
392 APPLICATION SITE ERYTHEMA 9 0.0003
393 PRODUCT LABEL CONFUSION 2 0.0003
394 SPINAL OSTEOARTHRITIS 3 0.0003
395 BACTERAEMIA 4 0.0003
396 INFUSION SITE REACTION 1 0.0003
397 PROTHROMBIN TIME PROLONGED 2 0.0003
398 ATYPICAL PNEUMONIA 1 0.0003
399 SYMPTOM RECURRENCE 2 0.0003
400 CEREBROVASCULAR DISORDER 1 0.0003
401 EMBOLISM VENOUS 1 0.0003
402 EYE INJURY 1 0.0003
403 KERATITIS 1 0.0003
404 IRITIS 1 0.0003
405 INJECTION SITE URTICARIA 8 0.0003
406 POOR QUALITY SLEEP 7 0.0003
407 SPINAL OPERATION 4 0.0003
408 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
409 DIASTOLIC DYSFUNCTION 1 0.0003
410 MULTIPLE-DRUG RESISTANCE 1 0.0003
411 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
412 SQUAMOUS CELL CARCINOMA 3 0.0003
413 INFUSION SITE SWELLING 2 0.0003
414 INFUSION SITE PRURITUS 1 0.0003
415 IRIDOCYCLITIS 1 0.0003
416 NON-CARDIAC CHEST PAIN 1 0.0003
417 FOREIGN BODY SENSATION IN EYES 2 0.0003
418 INJECTION SITE INDURATION 4 0.0003
419 HERPES SIMPLEX 2 0.0003
420 FACET JOINT SYNDROME 1 0.0003
421 SKIN BURNING SENSATION 22 0.0003
422 LYMPHOCYTE COUNT INCREASED 1 0.0003
423 INJECTION SITE INFECTION 1 0.0003
424 LACRIMATION INCREASED 9 0.0003
425 METASTASES TO SPINE 1 0.0003
426 CANDIDA INFECTION 5 0.0003
427 APPLICATION SITE DRYNESS 1 0.0003
428 HEPATIC CYST 1 0.0003
429 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
430 HYPOPNOEA 1 0.0003
431 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
432 SKIN IRRITATION 13 0.0003
433 DEPRESSIVE SYMPTOM 1 0.0003
434 HAND FRACTURE 2 0.0003
435 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
436 THERMAL BURN 2 0.0003
437 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
438 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
439 UTERINE LEIOMYOMA 2 0.0003
440 ORAL DISORDER 2 0.0003
441 ALCOHOL USE 1 0.0003
442 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
443 SUNBURN 2 0.0003
444 BONE DENSITY ABNORMAL 1 0.0003
445 INJECTION SITE PAIN 82 0.0003
446 BLISTER 15 0.0003
447 EYE INFECTION 3 0.0003
448 HEPATIC NECROSIS 1 0.0003
449 AUTOIMMUNE THYROIDITIS 1 0.0003
450 CATHETER SITE INFECTION 1 0.0003
451 SLEEP APNOEA SYNDROME 5 0.0003
452 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
453 APHTHOUS ULCER 2 0.0003
454 MUSCLE RUPTURE 1 0.0003
455 ASTHMA 29 0.0003
456 GASTROINTESTINAL INFLAMMATION 2 0.0003
457 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
458 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
459 EYE PAIN 14 0.0002
460 LOCALISED INFECTION 6 0.0002
461 RHINITIS 2 0.0002
462 APPLICATION SITE DISCOLOURATION 1 0.0002
463 ANAPHYLACTOID REACTION 1 0.0002
464 APPLICATION SITE EXFOLIATION 1 0.0002
465 PHARYNGITIS 3 0.0002
466 APPLICATION SITE IRRITATION 3 0.0002
467 PNEUMONIA ASPIRATION 6 0.0002
468 INJECTION SITE DISCOLOURATION 3 0.0002
469 DERMATITIS ALLERGIC 3 0.0002
470 INTERVERTEBRAL DISC DISORDER 1 0.0002
471 ABNORMAL SENSATION IN EYE 1 0.0002
472 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
473 INJECTION SITE REACTION 16 0.0002
474 MYOPATHY 2 0.0002
475 MUSCLE STRAIN 2 0.0002
476 NAIL DISORDER 2 0.0002
477 MELANOCYTIC NAEVUS 1 0.0002
478 DEPRESSED MOOD 12 0.0002
479 ABDOMINAL ABSCESS 1 0.0002
480 MENINGITIS ASEPTIC 1 0.0002
481 INJECTION SITE SWELLING 17 0.0002
482 PRODUCT DOSE OMISSION ISSUE 65 0.0002
483 LUPUS-LIKE SYNDROME 2 0.0002
484 HIDRADENITIS 2 0.0002
485 LUMBAR VERTEBRAL FRACTURE 1 0.0002
486 RETINAL DETACHMENT 2 0.0002
487 CONDITION AGGRAVATED 66 0.0002
488 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
489 FEELING OF DESPAIR 1 0.0002
490 APPENDICITIS 2 0.0002
491 BURNING SENSATION 15 0.0002
492 ABORTION INDUCED 2 0.0002
493 STAPHYLOCOCCAL INFECTION 7 0.0002
494 PRODUCT PRESCRIBING ERROR 5 0.0002
495 SKIN DISORDER 7 0.0002
496 ENDOMETRIOSIS 1 0.0002
497 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
498 HERPES ZOSTER 12 0.0002
499 INFECTION 30 0.0002
500 ENTEROCOCCAL INFECTION 1 0.0002
501 VITREOUS FLOATERS 2 0.0002
502 HYPERVOLAEMIA 1 0.0002
503 DRUG INEFFECTIVE 266 0.0002
504 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
505 ABDOMINAL TENDERNESS 1 0.0002
506 HYPERNATRAEMIA 1 0.0002
507 DERMATITIS EXFOLIATIVE 1 0.0002
508 BRAIN INJURY 2 0.0002
509 LYMPHADENOPATHY 7 0.0002
510 KLEBSIELLA INFECTION 1 0.0002
511 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
512 VISION BLURRED 27 0.0002
513 INSURANCE ISSUE 3 0.0002
514 FEELING HOT 12 0.0002
515 INJECTION SITE WARMTH 4 0.0002
516 HYPERBILIRUBINAEMIA 2 0.0002
517 VENTRICULAR EXTRASYSTOLES 2 0.0002
518 BRAIN FOG 3 0.0002
519 FOLLICULITIS 2 0.0002
520 CATATONIA 1 0.0002
521 GASTROINTESTINAL DISORDER 17 0.0002
522 RESPIRATORY TRACT CONGESTION 3 0.0002
523 EAR INFECTION 5 0.0002
524 SURGERY 11 0.0002
525 HEPATIC FUNCTION ABNORMAL 7 0.0002
526 ANAL FISTULA 1 0.0002
527 FOOD POISONING 1 0.0002
528 COMPRESSION FRACTURE 1 0.0002
529 INJECTION SITE DISCHARGE 1 0.0002
530 BEHAVIOUR DISORDER 1 0.0002
531 FUNGAL INFECTION 6 0.0002
532 INTERMENSTRUAL BLEEDING 1 0.0002
533 RASH PAPULAR 4 0.0002
534 SNEEZING 4 0.0002
535 THROAT IRRITATION 8 0.0002
536 COLECTOMY 1 0.0002
537 REBOUND EFFECT 2 0.0002
538 SCAR 3 0.0002
539 MICTURITION URGENCY 2 0.0002
540 MUSCULOSKELETAL DISCOMFORT 3 0.0002
541 EXERCISE TOLERANCE DECREASED 1 0.0002
542 ENTEROCOLITIS 1 0.0002
543 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
544 ELECTROLYTE IMBALANCE 2 0.0002
545 EOSINOPHILIA 3 0.0002
546 ASCITES 5 0.0002
547 BRADYKINESIA 1 0.0002
548 SWELLING FACE 11 0.0002
549 CATARACT OPERATION 1 0.0002
550 CARDIAC PACEMAKER INSERTION 1 0.0002
551 ADVERSE DRUG REACTION 15 0.0002
552 WRIST FRACTURE 2 0.0002
553 INJECTION SITE VESICLES 1 0.0002
554 ILLNESS 17 0.0002
555 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
556 PANIC ATTACK 6 0.0002
557 NEURALGIA 4 0.0002
558 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
559 INJECTION SITE RASH 5 0.0002
560 BLOOD GLUCOSE ABNORMAL 3 0.0002
561 ILEUS 2 0.0002
562 LOWER LIMB FRACTURE 3 0.0002
563 MYDRIASIS 2 0.0002
564 NODULE 2 0.0002
565 EYE DISORDER 5 0.0002
566 TOOTH INFECTION 2 0.0002
567 INJECTION SITE BRUISING 12 0.0002
568 TYPE 2 DIABETES MELLITUS 5 0.0001
569 EXTRA DOSE ADMINISTERED 6 0.0001
570 SINUS CONGESTION 2 0.0001
571 UVEITIS 2 0.0001
572 GINGIVAL BLEEDING 2 0.0001
573 SINUSITIS 15 0.0001
574 TREATMENT NONCOMPLIANCE 8 0.0001
575 PRODUCT PREPARATION ERROR 3 0.0001
576 APPLICATION SITE RASH 2 0.0001
577 ENCEPHALITIS 1 0.0001
578 ORAL DISCOMFORT 2 0.0001
579 HYPERTRANSAMINASAEMIA 1 0.0001
580 EXTRASYSTOLES 1 0.0001
581 COVID-19 25 0.0001
582 APPLICATION SITE REACTION 1 0.0001
583 SKIN REACTION 2 0.0001
584 LYMPHOPENIA 2 0.0001
585 METASTASIS 1 0.0001
586 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
587 GASTROENTERITIS 2 0.0001
588 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
589 INFLAMMATION 7 0.0001
590 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
591 IMMUNODEFICIENCY 2 0.0001
592 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
593 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
594 PRODUCT USE ISSUE 25 0.0001
595 CHROMATURIA 3 0.0001
596 DEVICE FAILURE 2 0.0001
597 ACIDOSIS 1 0.0001
598 LIPASE INCREASED 1 0.0001
599 DEVICE RELATED INFECTION 2 0.0001
600 APNOEA 1 0.0001
601 BASAL CELL CARCINOMA 2 0.0001
602 NASAL DISCOMFORT 1 0.0001
603 BLOOD ALBUMIN DECREASED 1 0.0001
604 GINGIVAL PAIN 1 0.0001
605 FRUSTRATION TOLERANCE DECREASED 1 0.0001
606 ARTHRALGIA 51 0.0001
607 HICCUPS 1 0.0001
608 ESCHERICHIA INFECTION 1 0.0001
609 HAIR DISORDER 1 0.0001
610 INJECTION SITE PRURITUS 8 0.0001
611 URTICARIA 20 0.0001
612 NASOPHARYNGITIS 22 0.0001
613 NASAL CONGESTION 7 0.0001
614 OFF LABEL USE 103 0.0001
615 SWELLING 11 0.0001
616 HEPATITIS 3 0.0001
617 DRUG RESISTANCE 3 0.0001
618 INFLUENZA 13 0.0001
619 INSOMNIA 31 0.0001
620 ANURIA 1 0.0001
621 BLOOD MAGNESIUM DECREASED 1 0.0001
622 HYPOXIA 4 0.0001
623 IMMUNOSUPPRESSION 1 0.0001
624 LUNG INFILTRATION 1 0.0001
625 HYPERSENSITIVITY 21 0.0001
626 DRUG ERUPTION 2 0.0001
627 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
628 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
629 FACIAL PAIN 1 0.0001
630 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
631 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
632 GASTROINTESTINAL INFECTION 1 0.0001
633 MYOSITIS 1 0.0001
634 HEAVY MENSTRUAL BLEEDING 1 0.0001
635 COUGH 31 0.0001
636 TOOTHACHE 2 0.0001
637 LIMB INJURY 3 0.0001
638 PAIN 67 0.0001
639 NERVE COMPRESSION 1 0.0001
640 IRON DEFICIENCY ANAEMIA 1 0.0001
641 INJECTION SITE MASS 4 0.0001
642 JOINT SWELLING 13 0.0001
643 HEPATIC STEATOSIS 2 0.0001
644 WOUND 3 0.0001
645 NEPHROPATHY 1 0.0001
646 MIDDLE INSOMNIA 2 0.0001
647 DIARRHOEA HAEMORRHAGIC 1 0.0001
648 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
649 PHOTOPHOBIA 2 0.0001
650 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
651 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
652 MIGRAINE 10 0.0001
653 CHOLESTASIS 2 0.0001
654 COELIAC DISEASE 1 0.0001
655 MEMORY IMPAIRMENT 14 0.0001
656 LIGAMENT SPRAIN 1 0.0001
657 SINUS DISORDER 2 0.0001
658 EMBEDDED DEVICE 1 0.0001
659 INABILITY TO AFFORD MEDICATION 1 0.0001
660 URINARY TRACT INFECTION 17 0.0001
661 CORONARY ARTERY DISEASE 3 0.0001
662 PRODUCT ADMINISTRATION ERROR 2 0.0001
663 HYPOTHERMIA 1 0.0001
664 EAR DISCOMFORT 1 0.0001
665 LUNG NEOPLASM MALIGNANT 4 0.0001
666 RIB FRACTURE 2 0.0001
667 LIMB DISCOMFORT 3 0.0001
668 VISUAL IMPAIRMENT 12 0.0001
669 INCORRECT DOSE ADMINISTERED 22 0.0001
670 ABDOMINAL DISTENSION 10 0.0001
671 DRUG-INDUCED LIVER INJURY 3 0.0001
672 PARAESTHESIA 15 0.0001
673 MOUTH ULCERATION 2 0.0001
674 INCONTINENCE 1 0.0001
675 EATING DISORDER 2 0.0001
676 RETCHING 2 0.0001
677 WEIGHT INCREASED 21 0.0001
678 BREAST PAIN 1 0.0001
679 IMPAIRED WORK ABILITY 2 0.0001
680 BODY HEIGHT DECREASED 1 0.0001
681 HEREDITARY ANGIOEDEMA 1 0.0001
682 NIGHT SWEATS 3 0.0001
683 ACNE 7 0.0001
684 CHRONIC KIDNEY DISEASE 7 0.0001
685 ALOPECIA 18 0.0001
686 IMPAIRED HEALING 3 0.0001
687 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
688 INJECTION SITE NODULE 1 0.0001
689 DENTAL CARIES 1 0.0001
690 VIRAL INFECTION 3 0.0001
691 HYPERTENSIVE CRISIS 1 0.0001
692 ORAL PAIN 2 0.0001
693 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
694 FISTULA 1 0.0001
695 INTERNAL HAEMORRHAGE 1 0.0001
696 TINNITUS 4 0.0001
697 LETHARGY 5 0.0001
698 GASTRIC HAEMORRHAGE 1 0.0001
699 NIGHTMARE 3 0.0001
700 MADAROSIS 1 0.0001
701 HAEMORRHAGE 9 0.0001
702 EYELID OEDEMA 1 0.0001
703 COVID-19 PNEUMONIA 1 0.0001
704 PERIPHERAL SWELLING 13 0.0001
705 NEUROPATHY PERIPHERAL 8 0.0001
706 CATARACT 5 0.0001
707 CHOLECYSTITIS 1 0.0001
708 PYREXIA 29 0.0001
709 MACULAR DEGENERATION 1 0.0001
710 HYPERLIPIDAEMIA 1 0.0001
711 MUSCLE RIGIDITY 1 0.0001
712 DEPRESSION 19 0.0001
713 CONTUSION 8 0.0001
714 DEHYDRATION 11 0.0001
715 STOMATITIS 5 0.0001
716 BURSITIS 1 0.0001
717 NOCTURIA 1 0.0001
718 HYPERGLYCAEMIA 3 0.0001
719 FIBROMYALGIA 2 0.0001
720 ENCEPHALOPATHY 2 0.0001
721 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
722 CARDIOMEGALY 1 0.0001
723 HYPERCALCAEMIA 1 0.0001
724 HEART RATE INCREASED 8 0.0001
725 INJECTION SITE ERYTHEMA 10 0.0001
726 CYST 1 0.0001
727 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
728 HYPERTENSION 17 0.0001
729 EPISTAXIS 6 0.0001
730 AGEUSIA 2 0.0001
731 HYPOAESTHESIA 12 0.0001
732 DYSPNOEA EXERTIONAL 3 0.0001
733 CELLULITIS 4 0.0001
734 UNEVALUABLE EVENT 6 0.0001
735 ABDOMINAL PAIN LOWER 2 0.0001
736 FLUID RETENTION 4 0.0001
737 INJECTION SITE IRRITATION 1 0.0001
738 SEIZURE 9 0.0001
739 ABDOMINAL PAIN UPPER 16 0.0001
740 ANOREXIA 1 0.0001
741 BACK PAIN 18 0.0001
742 SKIN ULCER 2 0.0001
743 RHINORRHOEA 5 0.0001
744 RESPIRATORY TRACT INFECTION 2 0.0001
745 PRODUCT DOSE OMISSION 5 0.0001
746 JOINT STIFFNESS 2 0.0001
747 BEDRIDDEN 1 0.0001
748 IMMUNE SYSTEM DISORDER 1 0.0001
749 ANKYLOSING SPONDYLITIS 1 0.0001
750 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
751 HAIR TEXTURE ABNORMAL 1 0.0001
752 PAIN IN EXTREMITY 22 0.0001
753 FATIGUE 58 0.0001
754 BLOOD BILIRUBIN INCREASED 2 0.0001
755 FREQUENT BOWEL MOVEMENTS 2 0.0001
756 DRY MOUTH 6 0.0001
757 DRUG TOXICITY 1 0.0001
758 ACUTE HEPATIC FAILURE 1 0.0001
759 CORONARY ARTERY OCCLUSION 1 0.0001
760 PROCEDURAL PAIN 2 0.0001
761 MENTAL STATUS CHANGES 2 0.0001
762 FEELING COLD 2 0.0001
763 HUNGER 1 0.0001
764 HEADACHE 45 0.0001
765 APHONIA 1 0.0001
766 MASS 1 0.0001
767 CARPAL TUNNEL SYNDROME 1 0.0001
768 DYSPEPSIA 7 0.0001
769 DEVICE OCCLUSION 1 0.0001
770 FLATULENCE 4 0.0001
771 SYNCOPE 7 0.0001
772 HYPOTENSION 14 0.0001
773 PANCREATIC CARCINOMA 2 0.0001
774 SEPTIC SHOCK 3 0.0001
775 INJECTION SITE HAEMATOMA 1 0.0001
776 INTENTIONAL PRODUCT MISUSE 6 0.0001
777 DYSSTASIA 2 0.0001
778 MUSCULOSKELETAL STIFFNESS 6 0.0001
779 COLON CANCER 1 0.0001
780 HAEMORRHAGE INTRACRANIAL 1 0.0001
781 RESPIRATORY DISORDER 2 0.0001
782 BLOOD POTASSIUM DECREASED 2 0.0001
783 ILL-DEFINED DISORDER 4 0.0001
784 ABDOMINAL DISCOMFORT 11 0.0001
785 HOSPITALISATION 10 0.0001
786 EMOTIONAL DISORDER 2 0.0001
787 PNEUMONIA 21 0.0001
788 LYMPHOMA 1 0.0001
789 MYALGIA 11 0.0001
790 FEMUR FRACTURE 2 0.0001
791 LUNG INFECTION 1 0.0001
792 EJECTION FRACTION DECREASED 1 0.0001
793 CYANOSIS 1 0.0001
794 ARTHRITIS 5 0.0001
795 PRODUCTIVE COUGH 3 0.0001
796 ABSCESS 1 0.0001
797 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
798 LACTIC ACIDOSIS 2 0.0001
799 MUSCLE TIGHTNESS 1 0.0001
800 BACK DISORDER 1 0.0001
801 BLOOD CREATININE INCREASED 4 0.0001
802 CHOLELITHIASIS 2 0.0001
803 METASTASES TO BONE 1 0.0001
804 INFLUENZA LIKE ILLNESS 5 0.0001
805 EXPIRED PRODUCT ADMINISTERED 2 0.0001
806 LIP SWELLING 2 0.0001
807 COAGULOPATHY 1 0.0001
808 BLOOD UREA INCREASED 1 0.0001
809 HEMIPARESIS 1 0.0001
810 BLOOD PRESSURE INCREASED 9 0.0001
811 WEIGHT DECREASED 16 0.0001
812 DEVICE USE ISSUE 1 0.0001
813 PRODUCT STORAGE ERROR 5 0.0001
814 COLD SWEAT 1 0.0001
815 DYSPNOEA 32 0.0001
816 ANXIETY 16 0.0001
817 GALLBLADDER DISORDER 1 0.0001
818 DECREASED APPETITE 13 0.0001
819 GASTROENTERITIS VIRAL 1 0.0001
820 COMPLICATION OF DEVICE REMOVAL 1 0.0001
821 CRYING 2 0.0001
822 C-REACTIVE PROTEIN INCREASED 2 0.0001
823 MUSCLE SPASMS 10 0.0001
824 ADVERSE EVENT 5 0.0001
825 DIZZINESS 27 0.0001
826 OROPHARYNGEAL PAIN 5 0.0001
827 CHEST PAIN 10 0.0001
828 ARTHROPATHY 3 0.0001
829 SEPSIS 6 0.0001
830 NECK PAIN 3 0.0001
831 BACTERIAL INFECTION 1 0.0001
832 OXYGEN SATURATION DECREASED 3 0.0001
833 HEPATIC CIRRHOSIS 1 0.0001
834 HOT FLUSH 4 0.0001
835 BLOOD SODIUM DECREASED 1 0.0001
836 FOOT FRACTURE 1 0.0001
837 DYSPHAGIA 5 0.0001
838 DIARRHOEA 34 0.0001
839 FEELING JITTERY 1 0.0001
840 INCREASED APPETITE 1 0.0001
841 ACUTE RESPIRATORY FAILURE 1 0.0001
842 ABDOMINAL PAIN 12 0.0001
843 DYSTONIA 1 0.0001
844 EAR PAIN 1 0.0001
845 HAEMORRHOIDS 1 0.0001
846 KIDNEY INFECTION 1 0.0001
847 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
848 INJECTION SITE HAEMORRHAGE 4 0.0001
849 FEELING ABNORMAL 12 0.0001
850 CARDIAC FAILURE 4 0.0000
851 CONFUSIONAL STATE 8 0.0000
852 FEEDING DISORDER 1 0.0000
853 VERTIGO 3 0.0000
854 INJURY ASSOCIATED WITH DEVICE 1 0.0000
855 BODY TEMPERATURE INCREASED 1 0.0000
856 OSTEOPOROSIS 2 0.0000
857 EXPOSURE DURING PREGNANCY 3 0.0000
858 WITHDRAWAL SYNDROME 2 0.0000
859 OSTEOARTHRITIS 2 0.0000
860 RENAL FAILURE ACUTE 2 0.0000
861 IRRITABLE BOWEL SYNDROME 1 0.0000
862 HYPERHIDROSIS 6 0.0000
863 BALANCE DISORDER 4 0.0000
864 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
865 MENTAL DISORDER 2 0.0000
866 MELAENA 1 0.0000
867 FALL 15 0.0000
868 COLITIS ULCERATIVE 2 0.0000
869 VOMITING 21 0.0000
870 DEVICE ISSUE 4 0.0000
871 HEART RATE IRREGULAR 1 0.0000
872 NAUSEA 35 0.0000
873 RHEUMATOID ARTHRITIS 5 0.0000
874 NEPHROLITHIASIS 2 0.0000
875 MUSCLE TWITCHING 1 0.0000
876 HYPOKALAEMIA 2 0.0000
877 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
878 CHILLS 5 0.0000
879 DISEASE PROGRESSION 5 0.0000
880 ARRHYTHMIA 2 0.0000
881 DISEASE RECURRENCE 2 0.0000
882 THERAPY INTERRUPTED 3 0.0000
883 GAIT DISTURBANCE 8 0.0000
884 BLOOD PRESSURE FLUCTUATION 1 0.0000
885 BLOOD GLUCOSE DECREASED 2 0.0000
886 DIABETIC KETOACIDOSIS 1 0.0000
887 HYPOGLYCAEMIA 2 0.0000
888 FLUSHING 4 0.0000
889 CHEST DISCOMFORT 4 0.0000
890 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
891 THERAPY CESSATION 2 0.0000
892 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
893 MUCOSAL INFLAMMATION 1 0.0000
894 MUSCULOSKELETAL PAIN 2 0.0000
895 ANHEDONIA 1 0.0000
896 RENAL FAILURE 5 0.0000
897 PLATELET COUNT DECREASED 4 0.0000
898 OEDEMA 2 0.0000
899 MOOD ALTERED 1 0.0000
900 MALAISE 16 0.0000
901 CARDIAC ARREST 3 0.0000
902 ANAPHYLACTIC REACTION 2 0.0000
903 TREMOR 6 0.0000
904 DEMENTIA 1 0.0000
905 HYPERSOMNIA 1 0.0000
906 MYOCARDIAL INFARCTION 6 0.0000
907 NEEDLE ISSUE 1 0.0000
908 DYSPHONIA 2 0.0000
909 PALPITATIONS 4 0.0000
910 ACUTE MYOCARDIAL INFARCTION 1 0.0000
911 LABORATORY TEST ABNORMAL 1 0.0000
912 TACHYCARDIA 3 0.0000
913 WHEEZING 2 0.0000
914 IRRITABILITY 2 0.0000
915 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
916 OEDEMA PERIPHERAL 4 0.0000
917 ACUTE KIDNEY INJURY 5 0.0000
918 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
919 NERVOUS SYSTEM DISORDER 1 0.0000
920 BONE DENSITY DECREASED 1 0.0000
921 HEAD INJURY 1 0.0000
922 CYSTITIS 1 0.0000
923 HIP FRACTURE 1 0.0000
924 DRUG INTOLERANCE 3 0.0000
925 ATRIAL FIBRILLATION 3 0.0000
926 DEEP VEIN THROMBOSIS 2 0.0000
927 FEBRILE NEUTROPENIA 2 0.0000
928 BLOOD PRESSURE DECREASED 2 0.0000
929 NEOPLASM MALIGNANT 2 0.0000
930 ANGER 1 0.0000
931 CEREBROVASCULAR ACCIDENT 5 0.0000
932 GASTRIC DISORDER 1 0.0000
933 DELIRIUM 1 0.0000
934 HYPERKALAEMIA 1 0.0000
935 HEART RATE DECREASED 1 0.0000
936 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
937 DRUG EFFECT INCOMPLETE 1 0.0000
938 AGITATION 2 0.0000
939 DYSURIA 1 0.0000
940 BRONCHITIS 2 0.0000
941 DYSGEUSIA 2 0.0000
942 DYSARTHRIA 1 0.0000
943 COLITIS 1 0.0000
944 DRUG DEPENDENCE 4 0.0000
945 SOMNOLENCE 5 0.0000
946 DEVICE BREAKAGE 1 0.0000
947 DYSKINESIA 1 0.0000
948 BLINDNESS 1 0.0000
949 NEUTROPHIL COUNT DECREASED 1 0.0000
950 RENAL IMPAIRMENT 2 0.0000
951 HYPOACUSIS 1 0.0000
952 DEVICE DISLOCATION 1 0.0000
953 CONSTIPATION 5 0.0000
954 ANGIOEDEMA 1 0.0000
955 PRODUCT QUALITY ISSUE 3 0.0000
956 NEUTROPENIA 3 0.0000
957 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
958 BREAST CANCER 2 0.0000
959 BLOOD CHOLESTEROL INCREASED 1 0.0000
960 ASTHENIA 8 0.0000
961 PULMONARY EMBOLISM 2 0.0000
962 COMA 1 0.0000
963 ANAEMIA 4 0.0000
964 AGGRESSION 1 0.0000
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
966 NERVOUSNESS 1 0.0000
967 BRADYCARDIA 1 0.0000
968 DISTURBANCE IN ATTENTION 1 0.0000
969 DEPENDENCE 1 0.0000
970 HAEMATOCHEZIA 1 0.0000
971 HYPONATRAEMIA 1 0.0000
972 CONVULSION 1 0.0000
973 BONE PAIN 1 0.0000
974 LOSS OF CONSCIOUSNESS 2 0.0000
975 AMNESIA 1 0.0000
976 HEPATIC ENZYME INCREASED 1 0.0000
977 DEVICE MALFUNCTION 1 0.0000
978 INJURY 1 0.0000
979 MOBILITY DECREASED 1 0.0000
980 HALLUCINATION 1 0.0000
981 DIABETES MELLITUS 1 0.0000
982 DRUG INTERACTION 2 0.0000
983 CARDIAC FAILURE CONGESTIVE 1 0.0000
984 COMPLETED SUICIDE 1 0.0000
985 DEATH 10 0.0000
986 NO ADVERSE EVENT 2 0.0000
987 CARDIAC DISORDER 1 0.0000
988 OVERDOSE 2 0.0000
989 MUSCULAR WEAKNESS 1 0.0000
990 EMOTIONAL DISTRESS 1 0.0000
991 BLOOD GLUCOSE INCREASED 1 0.0000